These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15536333)

  • 1. Estrogen and progesterone receptor expression in uterine and extrauterine leiomyosarcomas: an immunohistochemical study.
    Kelley TW; Borden EC; Goldblum JR
    Appl Immunohistochem Mol Morphol; 2004 Dec; 12(4):338-41. PubMed ID: 15536333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma.
    Leitao MM; Soslow RA; Nonaka D; Olshen AB; Aghajanian C; Sabbatini P; Dupont J; Hensley M; Sonoda Y; Barakat RR; Anderson S
    Cancer; 2004 Sep; 101(6):1455-62. PubMed ID: 15316901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Areas with benign morphologic and immunohistochemical features are associated with some uterine leiomyosarcomas.
    Mittal K; Joutovsky A
    Gynecol Oncol; 2007 Feb; 104(2):362-5. PubMed ID: 17011615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical expression of estrogen and progesterone receptors and outcomes in patients with newly diagnosed uterine leiomyosarcoma.
    Leitao MM; Hensley ML; Barakat RR; Aghajanian C; Gardner GJ; Jewell EL; O'Cearbhaill R; Soslow RA
    Gynecol Oncol; 2012 Mar; 124(3):558-62. PubMed ID: 22085894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen and progesterone receptor expression in patients with uterine smooth muscle tumors.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
    Fertil Steril; 2004 Apr; 81(4):1062-6. PubMed ID: 15066464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical Uterine Smooth Muscle Tumors: A Retrospective Evaluation of Clinical and Pathologic Features.
    Maltese G; Fontanella C; Lepori S; Scaffa C; Fucà G; Bogani G; Provenzano S; Carcangiu ML; Raspagliesi F; Lorusso D
    Oncology; 2018; 94(1):1-6. PubMed ID: 28869928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of steroid receptors, Ki-67, and p53 in uterine leiomyosarcomas.
    Zhai YL; Kobayashi Y; Mori A; Orii A; Nikaido T; Konishi I; Fujii S
    Int J Gynecol Pathol; 1999 Jan; 18(1):20-8. PubMed ID: 9891238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cluster analysis of immunohistochemical markers in leiomyosarcoma delineates specific anatomic and gender subgroups.
    Carvalho JC; Thomas DG; Lucas DR
    Cancer; 2009 Sep; 115(18):4186-95. PubMed ID: 19626649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative immunohistochemical and molecular analysis of uterine and extrauterine leiomyosarcomas.
    Rao UN; Finkelstein SD; Jones MW
    Mod Pathol; 1999 Nov; 12(11):1001-9. PubMed ID: 10574596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of advanced uterine leiomyosarcoma with aromatase inhibitors.
    O'Cearbhaill R; Zhou Q; Iasonos A; Soslow RA; Leitao MM; Aghajanian C; Hensley ML
    Gynecol Oncol; 2010 Mar; 116(3):424-9. PubMed ID: 19932916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Ki-67, P53 and progesterone receptors in uterine smooth muscle tumors. Diagnostic value.
    Petrović D; Babić D; Forko JI; Martinac I
    Coll Antropol; 2010 Mar; 34(1):93-7. PubMed ID: 20437637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoexpression of progesterone receptor, epithelial growth factor receptor and galectin-3 in uterine smooth muscle tumors.
    Soltan MM; Albasry AM; Eldosouky MK; Abdelhamid HS
    Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):7-12. PubMed ID: 29729689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase 2 study of anastrozole in rare cohorts of patients with estrogen receptor/progesterone receptor positive leiomyosarcomas and carcinosarcomas of the uterine corpus: The PARAGON trial (ANZGOG 0903).
    Edmondson RJ; O'Connell RL; Banerjee S; Mileshkin L; Sykes P; Beale P; Fisher A; Bonaventura A; Millan D; Nottley S; Benson C; Hamilton A; Sjoquist K; Alexander L; Kelly C; Carty K; Divers L; Bradshaw N; Friedlander M;
    Gynecol Oncol; 2021 Dec; 163(3):524-530. PubMed ID: 34625284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study.
    Akhan SE; Yavuz E; Tecer A; Iyibozkurt CA; Topuz S; Tuzlali S; Bengisu E; Berkman S
    Gynecol Oncol; 2005 Oct; 99(1):36-42. PubMed ID: 15992918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical detection of receptors for oestrogen and progesterone in endometrial glands and stroma during the oestrous cycle in Nelore (Bos taurus indicus) cows.
    Martin I; Torres Neto R; Oba E; Buratini J; Binelli M; Laufer-Amorim R; Ferreira JC
    Reprod Domest Anim; 2008 Aug; 43(4):415-21. PubMed ID: 18179635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cyclooxygenase-2, c-kit, progesterone and estrogen receptors in uterine smooth muscle tumors: differential diagnosis.
    Comunoğlu NU; Durak H; Comunoğlu C; Ekici AI; Ozkan F; Akyildiz EU; Ilvan S; Calay Z; Molinas N
    APMIS; 2007 Jun; 115(6):726-35. PubMed ID: 17550381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of progesterone receptor and p53 expression in uterine smooth muscle tumors.
    Hewedi IH; Radwan NA; Shash LS
    Diagn Pathol; 2012 Jan; 7():1. PubMed ID: 22217299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive immunohistochemical analysis based on the origin of leiomyosarcoma.
    Bayçelebi D; Kefeli M; Yıldız L; Karagöz F
    Pol J Pathol; 2022; 73(3):233-243. PubMed ID: 36734438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen and progesterone receptor expression in patients with uterine leiomyosarcoma and correlation with different clinicopathological parameters.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Leodolter S; Mayerhofer K
    Anticancer Res; 2003; 23(1B):729-32. PubMed ID: 12680175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
    Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
    J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.